Doxorubicin, mesenchymal stem cell toxicity and antitumour activity: implications for clinical use
2018 ◽
Vol 70
(3)
◽
pp. 320-327
◽
2019 ◽
Vol 54
(S2)
◽
pp. 789-792
◽
2004 ◽
Vol 3
(1)
◽
pp. 102
2020 ◽
2020 ◽
Keyword(s):
Keyword(s):
2012 ◽
Vol 2
(1_suppl)
◽
pp. s-0032-1319994-s-0032-1319994
Keyword(s):